Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats

Shock

Volumn 17, Issue 1, 2002, Pages 70-76

  Da Silva Santos, José Eduardo ^a   Terluk, Márcia Ribeiro ^a   Assreuy, Jamil ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Aorta; Blood pressure; Lipopolysaccharide; Septic shock; Vasoplegia

Indexed keywords

1H (1,2,4)OXADIAZOLO(4,3 A) QUILOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)-QUILOXALIN-1-ONE; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXADIAZOLE DERIVATIVE; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM;

ANIMAL; AORTA; ARTICLE; BLOOD PRESSURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTOXEMIA; ENZYMOLOGY; IN VITRO STUDY; MALE; METABOLISM; RAT; TIME;

ANIMALS; AORTA; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXADIAZOLES; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; TETRAETHYLAMMONIUM; TIME FACTORS;

EID: 0036364148     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200201000-00012     Document Type: Article

References (35)

1. Brandtzaeg P: Significance and pathogenesis of septic shock. In: Rietschel ET, Wagner H (ed): Pathophysiology of Septic Shock: Current Topics in Microbiology and Immunology. Berlin: Springer-Verlag, pp 16-37, 1996.
2. Karima R, Matsumoto S, Higashi H, Matsushima K: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5:123-132, 1999.
3. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
4. Wu CC, Ruetten H, Thiemermann C: Comparison of the effects of aminoguanidine and N-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300:99-104, 1996.
5. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 259:H1038-H1043, 1990.
6. Gray GA, Schoot C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103: 1218-1224, 1991.
7. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
8. Szabó C: Role of nitric oxide in endotoxic shock: an overview of recent advances. Ann N Y Acad Sci 851:422-425, 1998.
9. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57, 1992.
10. Kilbourn RG, Szabó C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
11. Rees DD, Cellek S, Palmer RMJ, Moncada S: Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 173:541-547, 1990.
12. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752, 1990.
13. Scott JA, McCormack DG: Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 86:1739-1744, 1999.
14. Conner EM, Aiko S, Fernandez M, Battarbee HD, Gray L, Grisham MB: Duration of the hemodynamic effects of NG-nitro-L-arginine methyl ester in vivo. Nitric Oxide 4:85-93, 2000.
15. Karima R, Matsumoto S, Higashi H, Matsushima K: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5:123-132, 1999.
16. Cai M, Sakamoto A, Ogawa R: Inhibition of nitric oxide formation with L-canavanine attenuates endotoxin-induced vascular hyporeactivity in the rat. Eur J Pharmacol 295:215-220, 1996.
17. Salter M, Knowles RG, Moncada S: Widespread tissue distribution, species distribution and changes in activity of Ca2+-independent nitric oxide synthases. FEBS Lett 291:145-149, 1991.
18. Gardiner SM, Kemp PA, March JE, Bennett T: Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 116:2005-2016, 1995.
19. Silva-Santos JE, Assreuy J: Long-lasting changes of rat blood pressure to vasoconstrictors and vasodilators induced by nitric oxide donor infusion: involvement of potassium channels. J Pharmacol Exp Ther 290:380-387, 1999.
20. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LM, Moncada S, Carrier M, O'Donnell CA, Liew FY: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 81:211-215, 1994.
21. Wu XB, Brune B, von Appen F, Ullrich V: Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch Biochem Biophys 294:75-82, 1992.
22. Beasley J, McGuiggin: Inlerleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med 179:71-80, 1994.
23. Schmidt HHHW: NO, CO and OH: endogenous: endogenous soluble guanylyl cyclase-activating factor. FEBS Lett 307:102-107, 1992.
24. Wu CC, Chen SJ, Yen MH: Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats. Am J Physiol 275:H1148-H1157, 1998.
25. Hall S, Turcato S, Clapp L: Abnormal activation of K+ channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 224:184-190, 1996.
26. Chen SJ, Wu CC, Yen MH: Role of nitric oxide and K+-channels in vascular hyporeactivity induced by endotoxin. Naunyn-Schmiedeberg's Arch Pharmacol 359:493-499, 1999.
27. Chen S-J, Wu C-C, Yang S-N, Lin C-I, Yen M-H: Abnormal activation of K+ channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol 131:213-222, 2000.
28. Terluk MR, Silva-Santos JE, Assreuy J: Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta. Naunyn-Schmied Arch Pharmacol 361:477-483, 2000.
29. Bolotina VM, Najibe S, Palacino JJ, Pagano JP, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853, 1994.
30. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91:7573-7587, 1994.
31. George MJ, Shibata EF: Regulation of calcium-activated potassium channels by S-nitrosothiol compounds and cyclic guanosine monophosphate in rabbit coronary artery myocytes. J Investig Med 43:451-458, 1995.
32. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J: S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89:444-448, 1992.
33. De Kimpe SJ, Van Heuven-Nolsen D, van Amsterdam JG, Radomski MW, Nijkamp FP: Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther 268:910-915, 1994.
34. Marshall HE, Merchant K, Stamler JS: Nitrosation and oxidation in the regulation of gene expression. FASEB J 14:1889-1900, 2000.
35. Szabo C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78:1051-1063, 1996.